샘플 요청 목록

 카트 문의
시장보고서
상품코드
1576954

세계의 외과용 배액 디바이스 시장 : 인사이트, 경쟁 구도, 시장 예측(2030년)

Surgical Drainage Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
발행일: | 리서치사: DelveInsight | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

외과용 배액 디바이스 시장 규모는 2023년에 18억 5,000만 달러에 달했습니다. 이 시장은 2024-2030년의 예측 기간 중 5.67%의 CAGR로 확대하며, 2030년에는 25억 7,000만 달러에 달할 것으로 예측됩니다. 외과용 배액 디바이스 시장은 암 및 전립선 비대증(BPH) 등 만성질환의 유병률 상승, 비만으로 연결되는 좌식 라이프스타일에 의한 외과수술의 증가, 저침습외과수술에 대한 선호도의 증가에 의해 급속히 확대하고 있으며, 2024-2030년의 예측 기간 중 외과용 배액 디바이스 시장 전체의 성장을 가속시킬 것으로 예측됩니다.

또한 세계보건기구(WHO)가 2024년에 제공한 데이터에 따르면 국제암연구소(IARC)는 2022년에 전 세계에서 2,000만 건의 암이 새로 등록되었다고 밝혔습니다. 또한 같은 자료에 따르면 등록된 신규 암 사례 중 폐암은 전 세계에서 250만 건의 신규 사례를 차지하여 가장 흔한 암이 될 것이라고 합니다. 암 수술이 증가함에 따라 효율적인 체액 관리는 합병증을 예방하고 회복을 촉진하는 데 필수적이며, 이러한 장비는 암 치료 프로토콜에 필수적인 요소가 되고 있습니다. 이러한 추세는 환자의 안전과 최적의 치유를 보장하는 데 있으며, 외과용 배액 디바이스의 중요성이 증가하고 있으며, 따라서 암 환자 증가는 외과용 배액 디바이스 시장 수요를 주도하고 있습니다.

세계보건기구(WHO)가 제공한 데이터(2024년)에 따르면 2022년 전 세계 인구 8명 중 1명이 비만을 앓고 있는 것으로 나타났습니다. 또한 같은 자료에 따르면 2022년에는 약 25억 명이 과체중이며, 이 중 8억 9천만 명이 전 세계에서 비만과 함께 살고 있다고 합니다. 비만과 관련 합병증의 유병률이 전 세계에서 지속적으로 증가함에 따라 중증 비만에 대한 효과적인 치료법으로 비만 수술에 대한 수요가 증가하고 있습니다. 이러한 비만 수술 수요 증가는 이러한 수술에 사용되는 외과용 배액 디바이스에 대한 수요 증가와 직결됩니다.

따라서 위의 요인들은 종합적으로 전체 외과용 배액 디바이스 시장의 성장을 촉진할 것입니다.

그러나 외과용 배액 디바이스 사용에 따른 위험성, 대체 시술의 가용성 등이 외과용 배액 디바이스 시장의 성장에 도전이 될 수 있습니다.

세계의 외과용 배액 디바이스 시장에 대해 조사했으며, 시장의 개요와 유형별, 용도별, 최종사용자별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 제공하고 있습니다.

목차

제1장 외과용 배액 디바이스 시장 보고서 서론

제2장 외과용 배액 디바이스 시장의 개요

제3장 경쟁 구도

제4장 규제 분석

  • 미국
  • 유럽
  • 일본
  • 중국

제5장 외과용 배액 디바이스 시장의 주요 요인 분석

  • 외과용 배액 디바이스 시장 성장 촉진요인
  • 외과용 배액 디바이스 시장 성장 억제요인과 과제
  • 외과용 배액 디바이스 시장 기회

제6장 외과용 배액 디바이스 시장의 Porter's Five Forces 분석

제7장 외과용 배액 디바이스 시장 평가

  • 유형별
  • 용도별
  • 최종사용자별
  • 지역별

제8장 외과용 배액 디바이스 시장의 기업과 제품 개요

  • Medtronic
  • Cardinal Health Inc.
  • Zimmer Biomet
  • B. Braun Melsungen AG
  • Cook Medical
  • Acelity I.P Inc.
  • BD
  • Johnson & Johnson Services, Inc
  • Medela AG
  • ConvaTec Group Plc.
  • Romsons Group Private Ltd.
  • Redax S.P.A
  • Medline Industries Inc.
  • Integra LifeSciences
  • Poly Medicure
  • Global Medikit
  • Degania Silicone
  • Stryker
  • Teleflex Incorporated
  • Smith & Nephew plc.

제9장 KOL의 견해

제10장 프로젝트 어프로치

제11장 DelveInsight 소개

제12장 면책사항과 문의

KSA 24.10.31

Surgical Drainage Devices market by Type (Active [Jackson-Pratt Drains, Hemovac Drains, Blake Drains, Negative Pressure Wound Therapy, and Others], Passive [Penrose Drains and Others]), Application (General Surgery, Cardiovascular and Thoracic Surgery, Obstetric/Gynecological Surgery, Orthopedic Surgery, and Others), End-User (Hospitals, Ambulatory Surgery Centers, and Others) and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing prevalence of chronic disorders and growing number of surgical procedures worldwide

The surgical drainage devices market was valued at USD 1.85 billion in 2023 and is estimated to grow at a CAGR of 5.67% during the forecast period from 2024 to 2030 to reach USD 2.57 billion by 2030. The Surgical drainage devices market is expanding rapidly due to the increasing prevalence of chronic disorders such as cancers and benign prostatic hyperplasia (BPH), the growing number of surgical procedures due to a sedentary lifestyle leading to obesity, and the increasing preference for minimally invasive surgical procedures that are expected to escalate the overall growth of the surgical drainage devices market during the forecast period from 2024 to 2030.

Surgical drainage devices Market Dynamics:

The Global Cancer Observatory (2024), estimated that the new instances of cancer globally would reach from 20 million to 24.1 million 2030. Moreover, it stated that Asia accounted for 9,826,539 cancer cases, Europe accounted for 4,471,422 cancer cases, LAC accounted for 1,551,060 cancer cases, and Africa accounted for 1,185,216 cancer cases.

Also, data provided by the World Health Organization (WHO) in 2024, the International Agency for Research on Cancer (IARC) stated that 20 million new instances of cancer were registered in 2022 globally. Additionally, as per the same source, lung cancer accounted for 2.5 million new cases globally, of all the registered new cancer cases, making it the most common cancer. As cancer surgeries rise, efficient fluid management is essential to prevent complications and enhance recovery, making these devices indispensable in cancer treatment protocols. This trend highlights their growing importance in ensuring patient safety and optimal healing and hence rising cancer cases are driving demand for surgical drainage devices market.

Data from the National Institute of Health (2024) stated that the current prevalence of benign prostatic hyperplasia (BPH) is 50% to 60% for people in their 60s, increasing to 80% to 90% of those older than 70 years of age, globally. Moreover, the World Health Organization (2021) further stated that between 2015 and 2050, people between 60 years and above will double from 12 to 22%, and will eventually reach 2.1 billion by the year 2050, globally. As BPH leads to urinary retention, interventions such as catheterization and minimally invasive procedures often require drainage systems to manage fluids and reduce post-operative complications, particularly in older patients. This growing demographic is fueling the need for efficient drainage solutions in urological care.

According to the data provided by the World Health Organization (2024), in 2022 globally out of 8 people, 1 person was living with obesity. Furthermore, as per the same source in 2022, approximately 2.5 billion people were overweight and out of these 890 million people were living with obesity worldwide. As the prevalence of obesity and related comorbidities continues to rise globally, there is a growing demand for bariatric surgery as an effective treatment option for severe obesity. This increased demand for bariatric procedures directly translates to a higher demand for surgical drainage devices used in these surgeries.

Therefore, the factors stated above collectively will drive the overall surgical drainage devices market growth.

However, risks associated with the use of surgical drainage devices, availability of alternative procedures, and others may prove to be challenging factors for surgical drainage devices market growth.

Surgical drainage devices Market Segment Analysis:

Surgical Drainage Devices market by Type (Active [Jackson-Pratt Drains, Hemovac Drains, Blake Drains, Negative Pressure Wound Therapy, and Others], Passive [Penrose Drains and Others]), Application (General Surgery, Cardiovascular and Thoracic Surgery, Obstetric/Gynecological Surgery, Orthopedic Surgery, and Others), End-User (Hospitals, Ambulatory Surgery Centers, and Others) and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the type segment of the surgical drainage devices market, the negative pressure wound therapy, sub-category of active surgical drainage devices is expected to have a significant revenue share in the year 2023. This is because of the widespread uses and features of negative pressure wound therapy that enhance their utility and effectiveness.

One of the benefits is their convenience and ease of use, as these devices come pre-assembled and ready for immediate application, eliminating the need for complex setup and maintenance.

This streamlined approach reduces the risk of infection and simplifies the treatment process for healthcare providers. Additionally, negative pressure wound therapy devices are designed to be compact and portable, making them ideal for use in a variety of settings, including outpatient clinics and home care environments. Their disposable nature also minimizes the risk of cross-contamination and eliminates the need for time-consuming cleaning and reprocessing.

Moreover, new developments in the negative pressure wound therapy product lines and new product launches are bolstering the sub-category growth. For instance, in January 2022, Smith & Nephew plc added new indications for its Pico 7 and Pico 14 single-use negative pressure wound therapy (sNPWT) systems. The FDA cleared the London-based device maker's systems for reducing the incidence of both deep and superficial incisional surgical sites and dehiscence. The Pico 7Y system, which treated two wounds simultaneously, was also cleared to aid in the reduction of the incidence of superficial incisional SSIs for high-risk patients in class I wounds, post-operative seroma, and dehiscence.

Therefore the widespread uses and various features of negative pressure wound therapy enhance performance and usability, solidifying the significant impact on the growth of the overall surgical drainage devices market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall surgical drainage devices market:

Among all the regions, North America is expected to dominate the surgical drainage devices market in the year 2023 and is expected to do the same during the forecast period. This is driven by the increasing number of orthopedic surgeries along with rising aesthetic procedures in the region. Advancement in surgical drainage devices, regulatory support, and the introduction of innovative devices by key market players are acting as key factors contributing to the growth of the surgical drainage devices market in the North America region during the forecast period from 2024 to 2030.

According to the American Academy of Orthopaedic Surgeons (2024), in 2021 more than 100,000 shoulder replacement surgeries were performed annually in the U.S, encompassing total shoulder replacement, hemi arthroplasty, and reverse total shoulder replacement. As per the same source, it projects that by 2025, the number of shoulder replacement procedures in the U.S. could range between 174,000 and 350,000.

As per data by the International Society of Aesthetic Plastic Surgery (2023), the total number of aesthetic procedures that took place in the US were 6,196,701, including both surgical and non-surgical procedures. The US was also the country with the highest number of non-surgical procedures worldwide in 2023, with 4,405,599 procedures in 2023. The source further stated that the US was the country with the highest number of aesthetic surgeons globally, with 7,750 surgeons in 2023.

Since number of orthopedic and aesthetic surgeries are increasing, surgical drainage devices are essential in preventing complications such as infections and ensuring quicker recovery. As surgical complexity increases, advanced drainage systems become critical in improving patient outcomes and reducing hospital stays. Thereby escalating the market for surgical drainage devices.

Rising product developmental activities by regulatory bodies and key players in the region will further boost the market for surgical drainage devices. For example, in August 2021, OMAVAC Medical Solutions, Inc. announced the grant of a United States Patent, covering its SOMAVAC SVS Smart Suction Technology and surgical drain management platform.

Therefore, the interplay of all the aforementioned factors would provide a conducive growth environment for the North American surgical drainage devices market.

Surgical drainage devices Market key players:

Some of the key market players operating in the surgical drainage devices market include Medtronic, Cardinal Health Inc., Zimmer Biomet, B. Braun Melsungen AG, Cook Medical, Acelity I.P Inc., BD, Johnson & Johnson Services, Inc, Medela AG, ConvaTec Group Plc., Romsons Group Private Ltd., Redax S.P.A, Medline Industries Inc., Integra LifeSciences, Poly Medicure, Global Medikit, Degania Silicone, Stryker, Teleflex Incorporated, Smith & Nephew plc., and others.

Recent Developmental Activities in the surgical drainage devices Market:

  • In April 2022, Bearpac Medical and APR Medtech signed an exclusive distribution agreement for the sale of the Passio Pump Drainage System.
  • In August 2021, OMAVAC Medical Solutions, Inc. announced the granting of a United States Patent, covering its SOMAVAC SVS Smart Suction Technology and surgical drain management platform.

Key Takeaways from the surgical drainage devices Market Report Study

  • Market size analysis for current surgical drainage devices market size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the surgical drainage devices market.
  • Various opportunities available for the other competitors in the surgical drainage devices market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current surgical drainage devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for surgical drainage devices market growth in the coming future?

Target Audience who can be benefited from this surgical drainage devices Market Report Study

  • Surgical drainage devices product providers
  • Research organizations and consulting companies
  • Surgical drainage devices-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in Surgical drainage devices
  • Various end-users who want to know more about the surgical drainage devices market and the latest technological developments in the Surgical drainage devices market

Frequently Asked Questions for the surgical drainage devices Market:

1. What are surgical drainage devices?

  • The surgical drainage devices are tubes used in post-operative patient care, that are positioned close to surgical wounds to remove pus, blood, or other fluids and stop it from building up in the body. Surgical drains enable the drainage of liquid and/or gas from a wound or bodily cavity.

2. What is the market for surgical drainage devices?

  • The surgical drainage devices market was valued at USD 1.85 billion in 2023 and is estimated to grow at a CAGR of 5.67% during the forecast period from 2024 to 2030 to reach USD 2.57 billion by 2030.

3. What are the drivers for the surgical drainage devices market?

  • The Surgical drainage devices market is expanding rapidly due to the increasing prevalence of chronic disorders such as cancers and benign prostatic hyperplasia (BPH), the growing number of surgical procedures due to a sedentary lifestyle leading to obesity, and the increasing preference for minimally invasive surgical procedures that are expected to escalate the overall growth of the surgical drainage devices market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the surgical drainage devices market?

  • Some of the key market players operating in surgical drainage devices include Medtronic, Cardinal Health Inc., Zimmer Biomet, B. Braun Melsungen AG, Cook Medical, Acelity I.P Inc., BD, Johnson & Johnson Services, Inc, Medela AG, ConvaTec Group Plc., Romsons Group Private Ltd., Redax S.P.A, Medline Industries Inc., Integra LifeSciences, Poly Medicure, Global Medikit, Degania Silicone, Stryker, Teleflex Incorporated, Smith & Nephew plc., and others.

5. Which region has the highest share in the surgical drainage devices market?

  • Among all the regions, North America is expected to dominate the surgical drainage devices market in the year 2023 and is expected to do the same during the forecast period. This is driven by the increasing number of orthopedic surgeries along with rising aesthetic procedures in the region. Advancement in surgical drainage devices, regulatory support, and the introduction of innovative devices by key market players are acting as key factors contributing to the growth of the surgical drainage devices market in the North America region during the forecast period from 2024 to 2030.

Table of Contents

1. Surgical drainage devices Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Surgical drainage devices Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Surgical drainage devices Market Key Factors Analysis

  • 5.1. Surgical drainage devices Market Drivers
    • 5.1.1. Increasing prevalence of chronic disorders
    • 5.1.2. Increasing product developmental activities
    • 5.1.3. Growing number of surgical procedures
    • 5.1.4. Rising preference for minimally invasive devices
  • 5.2. Surgical drainage devices Market Restraints and Challenges
    • 5.2.1. Risks associated with the use of surgical drainage devices
    • 5.2.2. Availability of alternative procedures
  • 5.3. Surgical drainage devices Market Opportunities
    • 5.3.1. Development of smaller and more sophisticated drainage devices

6. Surgical drainage devices Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Surgical drainage devices Market Assessment

  • 7.1. By Type
    • 7.1.1. Active
      • 7.1.1.1. Jackson-Pratt Drains
      • 7.1.1.2. Hemovac Drains
      • 7.1.1.3. Blake Drains
      • 7.1.1.4. Negative Pressure Wound Therapy
      • 7.1.1.5. Others
    • 7.1.2. Passive
      • 7.1.2.1. Penrose Drains
      • 7.1.2.2. Others
  • 7.2. By Application
    • 7.2.1. General Surgery
    • 7.2.2. Cardiovascular and Thoracic Surgery
    • 7.2.3. Obstetric/Gynecological Surgery
    • 7.2.4. Orthopedic Surgery
    • 7.2.5. Others
  • 7.3. By End-User
    • 7.3.1. Hospitals
    • 7.3.2. Ambulatory Surgery Centers
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Surgical drainage devices Market Size in USD million (2021-2030)
      • 7.4.1.2. Canada Surgical drainage devices Market Size in USD million (2021-2030)
      • 7.4.1.3. Mexico Surgical drainage devices Market Size in USD million (2021-2030)
    • 7.4.2. Europe
      • 7.4.2.1. France Surgical drainage devices Market Size in USD million (2021-2030)
      • 7.4.2.2. Germany Surgical drainage devices Market Size in USD million (2021-2030)
      • 7.4.2.3. United Kingdom Surgical drainage devices Market Size in USD million (2021-2030)
      • 7.4.2.4. Italy Surgical drainage devices Market Size in USD million (2021-2030)
      • 7.4.2.5. Spain Surgical drainage devices Market Size in USD million (2021-2030)
      • 7.4.2.6. Rest of Europe Surgical drainage devices Market Size in USD million (2021-2030)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Surgical drainage devices Market Size in USD million (2021-2030)
      • 7.4.3.2. Japan Surgical drainage devices Market Size in USD million (2021-2030)
      • 7.4.3.3. India Surgical drainage devices Market Size in USD million (2021-2030)
      • 7.4.3.4. Australia Surgical drainage devices Market Size in USD million (2021-2030)
      • 7.4.3.5. South Korea Surgical drainage devices Market Size in USD million (2021-2030)
      • 7.4.3.6. Rest of Asia-Pacific Surgical drainage devices Market Size in USD million (2021-2030)
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East Surgical drainage devices Market Size in USD million (2021-2030)
      • 7.4.4.2. Africa Surgical drainage devices Market Size in USD million (2021-2030)
      • 7.4.4.3. South America Surgical drainage devices Market Size in USD million (2021-2030)

8. Surgical drainage devices Market Company and Product Profiles

  • 8.1. Medtronic
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Cardinal Health Inc.
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Zimmer Biomet
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. B. Braun Melsungen AG
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Cook Medical
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Acelity I.P Inc.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. BD
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Johnson & Johnson Services, Inc
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Medela AG
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. ConvaTec Group Plc.
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Romsons Group Private Ltd.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Redax S.P.A
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Medline Industries Inc.
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Integra LifeSciences
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Poly Medicure
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Global Medikit
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. Degania Silicone
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Stryker
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Teleflex Incorporated
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. Smith & Nephew plc.
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제